当前位置:首页 - 行情中心 - 第一医药(600833) - 财务分析 - 现金流量表

第一医药

(600833)

  

流通市值:23.38亿  总市值:23.38亿
流通股本:2.23亿   总股本:2.23亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,046,718,787.48515,989,005.692,318,053,301.691,652,800,908.61
  收到的税费返还6,243,434.36-9,288,614.099,023,181.95
  收到其他与经营活动有关的现金17,162,191.88,015,613.2441,985,335.3627,038,213.25
  经营活动现金流入小计1,070,124,413.64524,004,618.932,369,327,251.141,688,862,303.81
  购买商品、接受劳务支付的现金874,083,225.54423,779,496.451,888,641,702.011,327,757,284.68
  支付给职工以及为职工支付的现金67,343,472.7141,546,235.14194,697,548.9995,238,687.01
  支付的各项税费20,404,775.268,102,672.5960,356,287.734,630,124.03
  支付其他与经营活动有关的现金86,920,678.942,227,121.67136,751,208.6206,694,586.57
  经营活动现金流出小计1,048,752,152.41515,655,525.852,280,446,747.31,664,320,682.29
  经营活动产生的现金流量净额21,372,261.238,349,093.0888,880,503.8424,541,621.52
二、投资活动产生的现金流量:
  收回投资收到的现金130,000,00090,000,000343,700,027.78265,000,000
  取得投资收益收到的现金12,085,546.056,864,268.1118,639,088.5615,251,507.68
  处置固定资产、无形资产和其他长期资产收回的现金净额30,208,527.7810,340.0150,835,265.8254,091,026.11
  投资活动现金流入小计172,294,073.8396,874,608.12413,174,382.16334,342,533.79
  购建固定资产、无形资产和其他长期资产支付的现金4,937,002.932,564,174.1515,927,763.4112,789,546.09
  投资支付的现金88,000,00029,000,000433,025,027.78314,700,000
  投资活动现金流出小计92,937,002.9331,564,174.15448,952,791.19327,489,546.09
  投资活动产生的现金流量净额79,357,070.965,310,433.97-35,778,409.036,852,987.7
三、筹资活动产生的现金流量:
  取得借款收到的现金--99,289,263.8999,289,263.89
  筹资活动现金流入平衡项目--00
  筹资活动现金流入小计--99,289,263.8999,289,263.89
  偿还债务支付的现金49,652,722.2249,652,722.22144,283,575.0194,647,033.34
  分配股利、利润或偿付利息支付的现金17,746,676.74347,277.7850,791,648.5551,138,926.33
  支付其他与筹资活动有关的现金26,277,331.1112,678,239.4962,389,023.0444,591,269.72
  筹资活动现金流出小计93,676,730.0762,678,239.49257,464,246.6190,377,229.39
  筹资活动产生的现金流量净额-93,676,730.07-62,678,239.49-158,174,982.71-91,087,965.5
四、汇率变动对现金及现金等价物的影响-488,502.8-93,397.69-1,272,724.99-560,726.39
五、现金及现金等价物净增加额6,564,099.2610,887,889.87-106,345,612.89-60,254,082.67
  加:期初现金及现金等价物余额322,524,395.03322,224,697.48428,870,007.92428,870,007.92
  期末现金及现金等价物余额329,088,494.29333,112,587.35322,524,395.03368,615,925.25
补充资料:
  净利润26,491,984.88-58,536,397.11-
  资产减值准备--1,648,594.19-
  固定资产和投资性房地产折旧2,503,087.16-4,971,920.14-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧2,503,087.16-4,971,920.14-
  无形资产摊销1,580,279.78-3,152,727.73-
  长期待摊费用摊销3,610,475.59-7,741,676.44-
  处置固定资产、无形资产和其他长期资产的损失-30,729,859.6--50,179,480.75-
  固定资产报废损失462,386.02-340,144.76-
  公允价值变动损失-246,622.02-11,419.67-
  财务费用1,546,651.58-5,236,916.3-
  投资损失-6,538,626.74--11,073,990.93-
  递延所得税-19,137,332.02--3,545,115.27-
  其中:递延所得税资产减少-2,983,341.58--3,452,923.75-
    递延所得税负债增加-16,153,990.44--92,191.52-
  存货的减少-7,148,169.04--18,953,456.78-
  经营性应收项目的减少22,562,480.77--27,818,746.79-
  经营性应付项目的增加-595,054.39-56,592,595.28-
  现金的期末余额329,088,494.29-322,524,395.03-
  减:现金的期初余额322,524,395.03-428,870,007.92-
  现金及现金等价物的净增加额6,564,099.26--106,345,612.89-
公告日期2026-08-262026-04-302026-04-092025-10-31
审计意见(境内)标准无保留意见
TOP↑